ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Search for coronavirus cure boosted by go-ahead for Fujifilm's Avigan

Existing flu and HIV treatments come with promise -- and possible side effects

TOKYO -- Medical experts are turning to existing treatments for the flu, Ebola and other illnesses to save patients from the spreading pandemic amid a global push to develop a cure for the new coronavirus.

The Chinese government announced Tuesday that the influenza drug favipiravir, developed by a Fujifilm Holdings subsidiary and sold under the name Avigan, is effective against the coronavirus, based on a clinical trial of 200 patients.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more